PHARMACYCLICS INC 4
4 · PHARMACYCLICS INC · Filed Mar 6, 2014
Insider Transaction Report
Form 4
McGreivy Jesse
VP, Clinical Science
Transactions
- Exercise/Conversion
Common Stock
2014-03-05$25.33/sh+6,563$166,241→ 6,563 total - Sale
Common Stock
2014-03-05$139.66/sh−6,563$916,599→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-03-05−6,563→ 18,958 totalExercise: $25.00From: 2012-04-16Exp: 2022-04-16→ Common Stock (6,563 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest as follows: 25% of the shares subject to the option will vest on April 16, 2013 and 1/36th of the remaining shares will vest monthly thereafter.